Showing 2,161 - 2,180 results of 18,137 for search 'significantly ((((larger decrease) OR (greatest decrease))) OR (((we decrease) OR (a decrease))))', query time: 0.73s Refine Results
  1. 2161
  2. 2162
  3. 2163

    Table 1_DYRK1A roles in human neural progenitors.xlsx by Jeremie Courraud (20871932)

    Published 2025
    “…In addition, DYRK1A-KD led to a reduction in p21 protein levels, despite an increase in the expression of a minor transcript variant for this gene, and a decrease in ERK pathway activation.…”
  4. 2164

    Data Sheet 1_DYRK1A roles in human neural progenitors.docx by Jeremie Courraud (20871932)

    Published 2025
    “…In addition, DYRK1A-KD led to a reduction in p21 protein levels, despite an increase in the expression of a minor transcript variant for this gene, and a decrease in ERK pathway activation.…”
  5. 2165
  6. 2166

    S1 Data - by Bowen Deng (3123237)

    Published 2024
    “…</p><p>Results</p><p>Among 1,523 eligible patients, 227 (14.9%) died within 30 days. We identified 4 longitudinal trajectories of blood glucose, including class 1 (a low initial average blood glucose level with steady trend within 24 hours), class 2 (a high initial average blood glucose with gently decreased trend), class 3 (the highest initial average blood glucose with rapidly decreased trend) and class 4 (a high initial average blood glucose level with the trend that increased at first and then decreased). …”
  7. 2167

    Characteristics of AMI patients with DM. by Bowen Deng (3123237)

    Published 2024
    “…</p><p>Results</p><p>Among 1,523 eligible patients, 227 (14.9%) died within 30 days. We identified 4 longitudinal trajectories of blood glucose, including class 1 (a low initial average blood glucose level with steady trend within 24 hours), class 2 (a high initial average blood glucose with gently decreased trend), class 3 (the highest initial average blood glucose with rapidly decreased trend) and class 4 (a high initial average blood glucose level with the trend that increased at first and then decreased). …”
  8. 2168

    Four grid table. by Xiaoling Zhong (181270)

    Published 2025
    “…These methods were used to evaluate whether there is a significant association between finasteride drug use and AEs. …”
  9. 2169

    Four major algorithms used for signal detection. by Xiaoling Zhong (181270)

    Published 2025
    “…These methods were used to evaluate whether there is a significant association between finasteride drug use and AEs. …”
  10. 2170

    Presentation 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated... by Xiaokang Wang (733379)

    Published 2025
    “…The Nrf2 pathway and its related proteins involved in modifying P-glycoprotein (P-gp) expression were clarified by a series of immunoblot analyses.</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”
  11. 2171

    Table 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated signall... by Xiaokang Wang (733379)

    Published 2025
    “…The Nrf2 pathway and its related proteins involved in modifying P-glycoprotein (P-gp) expression were clarified by a series of immunoblot analyses.</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”
  12. 2172
  13. 2173
  14. 2174
  15. 2175

    S1 Data - by Hao Deng (409186)

    Published 2024
    “…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”
  16. 2176

    Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>. by Hao Deng (409186)

    Published 2024
    “…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”
  17. 2177
  18. 2178
  19. 2179
  20. 2180

    Data. by Su Hwan Park (15158181)

    Published 2025
    “…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”